Skip to main content

Want a detailed portfolio tracker?

Genenta Science SpA (GNTA) P/E (2021 - 2026)

Genenta Science SpA (GNTA) P/E from Dec 15, 2021 to Jul 21, 2026. The TTM Genenta Science SpA (GNTA) P/E is -5.04. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Genenta Science SpA (GNTA)

YearP/EChange
2026-5.04+10.74%
2025-4.55-47.22%
2024-8.63-13.48%
2023-9.97-37.46%
2022-15.94-49.82%
2021-31.77N/A

Comparison Genenta Science SpA (GNTA) P/E with competitors

Genenta Science SpA (GNTA) P/E is -5.04.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.03%
NBYStablecoin Development Corp0.00-100.09%
ENLVEnlivex Ltd0.07-101.48%
FGENFibroGen Inc0.24-104.76%
CHRSCoherus Biosciences Inc0.85-116.83%
FBIOFortress Biotech Inc0.95-118.83%
ORMPOramed Pharmaceuticals Inc1.50-129.81%
AGENAgenus Inc3.01-159.70%
INVAInnoviva Inc3.15-162.56%
VXRTVaxart Inc3.55-170.41%
CRMDCorMedix Inc3.63-171.97%
CVACCureVac N.V.4.45-188.18%
GLPGGalapagos NV4.86-196.38%
SRPTSarepta Therapeutics Inc4.88-196.84%
ABEOAbeona Therapeutics Inc5.39-206.87%
ABUSArbutus Biopharma Corp5.60-210.99%
ZVRAZevra Therapeutics Inc5.89-216.78%
SPROSpero Therapeutics Inc6.23-223.55%
CGENCompugen Ltd6.31-225.24%
RIGLRigel Pharmaceuticals6.87-236.31%
SLXNSilexion Therapeutics Corp7.30-244.72%
OMEROmeros Corporation9.26-283.66%
AUPHAurinia Pharmaceuticals Inc9.58-290.13%
PLXProtalix BioTherapeutics Inc10.89-316.03%
ACADAcadia Pharmaceuticals Inc11.73-332.65%
TBPHTheravance Biopharma Inc12.26-343.23%
ADMAAdma Biologics Inc12.42-346.33%
HRMYHarmony Biosciences Holdings Inc13.82-374.14%
SABSSAB Biotherapeutics Inc14.14-380.41%
NAGENiagen Bioscience Inc14.82-393.93%
INCYIncyte Corp15.82-413.86%
REGNRegeneron Pharmaceuticals Inc15.86-414.53%
PBYIPuma Biotechnology Inc17.32-443.47%
CPRXCatalyst Pharmaceuticals Inc17.44-445.93%
EXELExelixis Inc17.54-447.88%
TGTXTG Therapeutics Inc18.97-476.21%
MDXGMimedx Group Inc20.55-507.68%
XOMAXOMA Royalty Corp22.87-553.75%
ARGXArgen X SE24.30-581.99%
CTMXCytomX Therapeutics Inc24.82-592.36%
XOMAOXOMA Royalty Corp25.34-602.75%
HALOHalozyme Therapeutics Inc25.62-608.29%
XOMAPXOMA Royalty Corp25.67-609.21%
VRTXVertex Pharmaceuticals Inc27.99-655.32%
RPRXRoyalty Pharma plc - Class A28.69-669.06%
SLNOSoleno Therapeutics Inc29.02-675.56%
ASNDAscendis Pharma A/S30.09-696.79%
LGNDLigand Pharmaceuticals Inc - Class B37.91-852.04%
APLSApellis Pharmaceuticals Inc39.02-874.05%
BMRNBiomarin Pharmaceutical Inc42.21-937.34%
KRYSKrystal Biotech Inc45.34-999.46%
ONCBeiGene Ltd69.54-1479.44%
PHARPharming Group N.V.75.03-1588.25%
TECHBio-Techne Corp101.96-2122.50%
VCELVericel Corp109.92-2280.46%
ALNYAlnylam Pharmaceuticals Inc117.96-2440.02%
TLXTelix Pharmaceuticals Ltd162.15-3316.55%
CORTCorcept Therapeutics Inc212.86-4322.36%